Cargando…
Correction: Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389843/ https://www.ncbi.nlm.nih.gov/pubmed/28403229 http://dx.doi.org/10.1371/journal.pone.0175930 |
Ejemplares similares
-
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016) -
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Publicado: (2016) -
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
por: Konde, Mandy Kader, et al.
Publicado: (2017) -
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016) -
Correction to: Selenium supplementation in patients with peripartum cardiomyopathy: a proof‑of‑concept trial
por: Karaye, Kamilu M., et al.
Publicado: (2021)